Infertility / tubal pathology
Conditions
Interventions
Virtual Reality with the use of a ‘head mounted device’ (Sync VR Medical, Utrecht, The Netherlands) during the HSG. Participants will receive a demo of the VR device prior to the HSG and can choose be
Sponsors
Amsterdam UMC
Eligibility
Inclusion criteria
Inclusion criteria: Women who: - Will undergo an HSG with oil-based contrast for infertility - Have no history of cervical procedures - Speak Dutch or English
Exclusion criteria
Exclusion criteria: Women who: - Are on chronic pain medication - Use antidepressants or sedatives - Underwent an HSG before - Are unwilling or unable to give ‘informed consent’ - Are pregnant - Have a malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is pain during the HSG. This measure consists of two components: the most severe pain (using a visual analogue scale 0-10) and the overall pain (using a visual analogue scale 0-10) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are: - (Hypothetical) willingness to undergo another HSG if necessary - Use of oral analgesics during the first 24 hours after the HSG - ‘Immersiveness’ in the VR program - Side effects of the VR program | — |
Contacts
Public ContactKimmy Rosielle
Amsterdam UMC
Outcome results
None listed